E2F1 and melanoma: Its pro cancer mechanism mainly includes two aspects: on the one hand, DTL promotes the malignant progression of melanoma by reshaping the glucose metabolism process of tumor cells (46); On the other hand, it drives the proliferation and migration of melanoma cells via the ERK/E2F1/BUB1 signaling axis (49).